Brad W. Hansman - 01 Jun 2026 Form 3 Insider Report for Medpace Holdings, Inc. (MEDP)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
04 Jun 2026, 16:44:09 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Brad W. Hansman

Key filing fact

Brad W. Hansman filed Form 3 for Medpace Holdings, Inc. (MEDP) on 04 Jun 2026.

Key facts

  • This page summarizes Brad W. Hansman's Form 3 filing for Medpace Holdings, Inc. (MEDP).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2026, 16:44.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002137132 Primary reporting owner

Hansman Brad W.

Relationship
Exec. VP, Operations
Address
C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Brad W. Hansman
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
697
Date
01 Jun 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
Footnotes
F1, F2
MEDP holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
Footnotes
F2, F3
MEDP holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$410.54
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Footnote F3

The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Footnote F4

The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .